KR101739122B1 - Antibiotic composition having a wide scope of antibacterial activity untill drug resistance bacteria - Google Patents

Antibiotic composition having a wide scope of antibacterial activity untill drug resistance bacteria Download PDF

Info

Publication number
KR101739122B1
KR101739122B1 KR1020160119261A KR20160119261A KR101739122B1 KR 101739122 B1 KR101739122 B1 KR 101739122B1 KR 1020160119261 A KR1020160119261 A KR 1020160119261A KR 20160119261 A KR20160119261 A KR 20160119261A KR 101739122 B1 KR101739122 B1 KR 101739122B1
Authority
KR
South Korea
Prior art keywords
dried
powder
leaf powder
mixture
bacteria
Prior art date
Application number
KR1020160119261A
Other languages
Korean (ko)
Inventor
이우철
손화섭
허담
Original Assignee
동우당제약(주)
이우철
손화섭
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 동우당제약(주), 이우철, 손화섭 filed Critical 동우당제약(주)
Priority to KR1020160119261A priority Critical patent/KR101739122B1/en
Application granted granted Critical
Publication of KR101739122B1 publication Critical patent/KR101739122B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/40Cornaceae (Dogwood family)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0215Disinfecting agents, e.g. antimicrobials for preserving living parts
    • A01N63/02
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/24Lauraceae [Laurel family], e.g. laurel, avocado, sassafras, cinnamon or camphor
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/38Solanaceae [Potato family], e.g. nightshade, tomato, tobacco or chilli pepper
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815Lycium (desert-thorn)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention relates to an antibacterial composition exhibiting excellent and widespread antibacterial activity to antibiotic-resistant bacteria, such as super bacteria as well as general pathogenic strains. The antibacterial composition is manufactured by: injecting Lactobacillus plantarum to a mixture consisting of a dry Cornus officinalis leave powder, a dry Lycium chinense leave powder, a dry Lindera obtusiloba leaf powder, and a hive dried powder which completed honey extraction; culturing the mixture; and hot-water extracting the culture.

Description

항생제 내성을 가진 균까지 광범위한 항균 활성을 보이는 항균용 조성물{Antibiotic composition having a wide scope of antibacterial activity untill drug resistance bacteria}[0001] The present invention relates to an antibacterial composition having antibacterial activity against bacteria having antibiotic resistance,

본 발명은 광범위한 항균 활성을 가지는 항균용 조성물, 특히 슈퍼박테리아와 같은 항생제 내성균주에 대해서는 우수하면서 광범위한 항균 활성을 가지는 항균용 조성물에 관한 것이다.The present invention relates to a composition for antimicrobial activity having a wide range of antibacterial activity, and more particularly to a composition for antimicrobial activity having an excellent and broad antibacterial activity against antibiotic resistant bacteria such as super bacteria.

병원성 미생물에 의한 직접 혹은 간접적인 피해는 경제, 환경, 의학적으로 많은 문제를 야기시키고 있다. 식품산업에서의 식품 유통 과정 중의 부패로 인한 손실, 농산업에서의 농작물에 대한 과량의 화학 살충제의 사용으로 인한 인체의 유해성 및 환경오염, 항생제의 오남용으로 인한 항생제 내성 균주의 출현 등 사회 전반에서 많은 문제들을 야기시키고 있다.Direct or indirect damages caused by pathogenic microorganisms are causing economic, environmental and medical problems. The loss of food in the food industry due to corruption, the harmfulness and environmental pollution of the human body due to the use of excessive chemical pesticides in the agricultural industry, and the emergence of antibiotic resistant strains due to abuse of antibiotics. .

인체 감염의 가장 흔한 원인균인 황색포도상구균의 마지막 치료제로 알려진 반코마이신에 고도의 내성을 보이는 포도상구균(vancomycin-resistant staphylococcus aureus, VRSA)이, 2002년 미국 질병 통제국(Centers for Disease Control)에서 세계 최초로 보고됨으로써 소위 슈퍼 박테리아의 확산 가능성이 매우 높아지고 있다. 이는 반코마이신에 의해서만 치료가 되는 메치실린 내성 황색포도상구균(methicillin-resistant s. aureus,MRSA)이 1970년대부터 문제시된 이후 1988년 반코마이신에 내성을 보이는 장구균(vancomycin resistant enterococcus, VRE)이 유럽에서 처음으로 발견되었고, 1990년 후반에는 일본, 미국, 프랑스, 한국에서 보고된 반코마이신에 내성을 보이는 황색포도상구균(vancomycin intermediate-resistant s. aureus, VISA)이 발생하면서 범세계적인 위기로 떠오른 항생제 내성의 새로운 예로서 내성문제가 얼마나 심각한지를 보여 주고 있어 새로운 항생제 개발이 시급히 요구되고 있다(Pfeltz, R. F. and Wilkinson, B. J. 2004. The escalating challenge of vancomycin resistance in Staphylococcus aureus. Drug targets-infect. Disord. 4: 273-294.; Levy, S. B. and Marshall, B. 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nature Med. 10: 122-129.).Vancomycin-resistant staphylococcus aureus (VRSA), a highly resistant strain of vancomycin, known as the last treatment for Staphylococcus aureus, the most common cause of human infection, was first introduced by the Centers for Disease Control in 2002 As a result, the possibility of so-called super-bacteria spread is increasing. This is the first time in Europe that vancomycin resistant enterococcus (VRE) resistant to vancomycin in 1988 after methicillin-resistant S. aureus (MRSA), which is only treated by vancomycin, And vancomycin intermediate-resistant S. aureus (VISA), a vancomycin resistant strain reported in Japan, the United States, France and Korea in late 1990, is a new example of antibiotic resistance that has emerged as a global crisis (Pfeltz, RF and Wilkinson, BJ 2004. The escalating challenge of vancomycin resistance in Staphylococcus aureus. Drug targets-infect. Disord. 4: 273-294. ; Levy, SB and Marshall, B. 2004. Antibacterial resistance worldwide: 122-129.).

현재 사용되고 있는 대부분의 항생제는 화학적인 합성을 통해 제조된 것으로서 고비용이 소요되며 부작용을 유발하는 등의 많은 한계를 가지고 있다. Most of the currently used antibiotics are manufactured through chemical synthesis, which is costly and has many limitations such as causing side effects.

따라서, 최근에는 천연물로부터 새로운 항균물질을 분리하고자 하는 연구가 활발하게 진행되고 있다. 천연물로부터 새로운 항균물질을 분리하기 위해서는 항균 스펙트럼이 광범위하고 장기간 투여하여도 부작용이 없이 안전하여야 한다는 점 등을 고려해야 한다.Therefore, in recent years, studies for separating new antimicrobial substances from natural products have been actively conducted. In order to isolate new antimicrobial substances from natural products, it should be considered that the antimicrobial spectrum is wide and safe even without long-term administration without adverse effects.

대한민국 공개특허공보 제10-2013-0112322호Korean Patent Publication No. 10-2013-0112322

따라서 본 발명이 이루고자 하는 기술적 과제는 독성 및 부작용이 없는 천연물, 특히 식물의 추출물을 이용하여 광범위한 항균 활성이 가지며, 특히 슈퍼박테리아와 같은 항생제 내성균에도 우수한 항균 활성을 보이는 항균용 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide an antimicrobial composition exhibiting excellent antimicrobial activity against antibiotic resistant bacteria such as superbacteria, having a wide range of antimicrobial activity using natural products, especially plant extracts, free from toxicity and side effects.

상기 기술적 과제를 달성하기 위하여 본 발명은 건조한 산수유 잎 분말, 건조한 구기자 잎 분말 및 건조한 생강나무 잎 분말의 혼합물을 열수 추출하여 제조되는 것을 특징으로 하는 광범위한 항균 활성을 가지는 항균용 조성물을 제공한다.In order to accomplish the above object, the present invention provides an antimicrobial composition having a wide range of antimicrobial activity, which is prepared by subjecting a mixture of dried corn oil leaf powder, dried gugija leaf powder and dried ginger leaf powder to hot water extraction.

본 발명에 따른 광범위한 항균 활성을 가지는 항균용 조성물에 있어서,In the antimicrobial composition having a broad antibacterial activity according to the present invention,

상기 혼합물은 채밀이 완료된 벌집 건조 분말을 더 포함하는 것이 바람직하며, 더욱 바람직하게는 상기 혼합물에 락토바실러스 플란타룸(Lactobacillus plantarum)을 접종하고 배양한 후 배양물을 열수 추출하여 제조되는 것이다. Preferably, the mixture further comprises a honeycomb dried powder having been densified. More preferably, the mixture is prepared by inoculating Lactobacillus plantarum to the mixture, culturing the mixture, and then subjecting the culture to hot water extraction.

본 발명에 따른 광범위한 항균 활성을 가지는 항균용 조성물에 있어서,In the antimicrobial composition having a broad antibacterial activity according to the present invention,

상기 건조한 산수유 잎 분말, 건조한 구기자 잎 분말, 건조한 생강나무 잎 분말 및 채밀이 완료된 벌집 건조 분말의 중량 비율이 동일 비율인 것이 바람직하다.It is preferable that the weight ratio of the dried safflower powder, dried gugija leaf powder, dried ginger leaf powder and dried honeycomb dried powder is the same.

본 발명에 따른 광범위한 항균 활성을 가지는 항균용 조성물은 반코마이신 내성균주(VRE), 메치실린 내성균주(MRSA), 퀴놀론 내성균주(QRSA) 및 다제내성균주(MDR)에 대하여 항균 활성을 가진다.The antimicrobial composition having a broad antibacterial activity according to the present invention has antimicrobial activity against vancomycin resistant strain (VRE), methicillin resistant strain (MRSA), quinolone resistant resistant strain (QRSA) and multidrug resistant resistant strain (MDR).

본 발명에 따른 조성물은 일반 감수성 균주뿐만 아니라 슈퍼박테리아와 같은 다제내성균까지 광범위하면서도 뛰어난 항균 활성을 보이며 또한 독성이나 부작용이 없는 천연물 내지 식물 추출물을 이용한 것으로서 병원성 세균, 항생제 내성균에 의한 감염 질환의 예방 또는 치료에 유용하게 사용될 수 있다.The composition according to the present invention utilizes not only general susceptible strains but also multi-drug resistant bacteria such as super bacteria and exhibits excellent antimicrobial activity and also has no toxicity or side effects. It is used for preventing or preventing infectious diseases caused by pathogenic bacteria, antibiotic- And can be useful for treatment.

본 발명은 일반 병원성 균주뿐만 아니라 슈퍼박테리아와 같은 항생제 내성균주에 대해서도 우수한 항균 활성을 보이는 광범위한 항균 활성을 가지는 항균용 조성물에 관한 것으로서, 건조한 산수유 잎 분말, 건조한 구기자 잎 분말 및 건조한 생강나무 잎 분말의 혼합물을 열수 추출하여 제조되는 것을 특징으로 하는 광범위한 항균 활성을 가지는 항균용 조성물을 제공한다.The present invention relates to an antimicrobial composition having broad antibacterial activity that exhibits excellent antimicrobial activity against antibiotic resistant bacteria such as superb bacteria as well as general pathogenic bacteria. The present invention relates to a composition for antimicrobial activity, which comprises a dry powder of corn oil, dried gugija leaf powder and dried ginger leaf powder The present invention provides a composition for antimicrobial activity having a wide range of antibacterial activity, which is produced by subjecting a mixture to hot water extraction.

본 발명에서 사용되는 산수유 잎 분말은 산수유의 잎을 채취하여 건조하여 분말화한 것으로서 산수유의 잎은 어떠한 것이라도 제한이 없으나 특히 바람직한 것은 봄의 어린 잎도 아니고 가을의 단풍든 잎도 아닌 6월에서 8월 사이에 채집한 실록이 짙은 잎을 사용하는 것이다. 이와 같은 기준은 구기자 잎 분말, 생강나무 잎 분말 모두에 적용될 수 있는 기준이다.The leaves of the acidulant oil used in the present invention are obtained by picking and drying the leaves of the acidulant oil. The leaves of the acidulant are not particularly limited. However, particularly preferred are the leaves of the spring, not the leaves of the autumn, The unoccupied collection from August uses dark leaves. These criteria are applicable to both Gugija leaf powder and ginger leaf powder.

또한 건조한 산수유 잎 분말, 건조한 구기자 잎 분말 및 건조한 생강나무 잎 분말의 혼합물에 각각 비율은 특별한 제한이 없으나 동일한 비율을 가지는 것이 바람직하며, 열수 추출에서의 물과 혼합물의 비율, 시간, 사용하는 물의 종류는 본 발명이 속하는 기술 분야에 널리 알려진 것이라면 특별한 제한 없이 사용할 수 있다.Also, the ratio of the dried corn oil leaf powder, the dried Gujuga leaf powder and the dried ginger leaf powder to each other is not particularly limited, but it is preferable that they have the same ratio, and the ratio of water to the mixture in the hot water extraction, the time, Can be used without any particular limitation as long as it is well known in the art to which the present invention belongs.

본 발명에서의 산수유 나무는 학명이 Cornus officinalis S. et Z.으로서 높이는 7m로 연한 갈색인데 수피가 벗겨지며은 난형·타원형 또는 난상피침형으로 마주 난다. 길이 4∼12㎝, 너비 2.5∼6㎝로 표면은 녹색이며 복모(伏毛)가 약간 있고 뒷면은 연한 녹색이거나 흰빛이 돈다. Cornus wood in the present invention is the scientific name Cornus officinalis S. et Z. It is light brown with a height of 7m, but its bark is peeled off and faces oval, elliptical or ovate lanceolate. Length is 4 ~ 12㎝, width is 2.5 ~ 6㎝, surface is green, there is little bittern (伏 毛) and the back side is light green or white.

또한 산수유 나무는 꽃이 황색으로 3∼4월에 잎보다 먼저 피는데, 그 모양이 아름다워서 관상수로 많이 재배되며, 열매는 긴 타원형으로 8월에 익는다. 열매에는 코르닌·베르베날린·타닌·우르손·비타민A 등이 함유되어 있으며, 약리작용이 있는데, 그 약성은 온화하고 독이 없으며 맛이 시고 달며, 신장기능과 생식기능의 감퇴로 소변을 자주 보거나, 야뇨·두훈(頭暈), 이명과 허리와 무릎이 시리고 은근히 통증을 느낄 때 복용하면 효과가 있다. In addition, the peduncle is yellow in color and blooms earlier than leaves in April to April. Its shape is beautiful and it is cultivated much as ornamental water. The fruit is long elliptical and ripens in August. The fruit contains cornin, verbellin, tannin, ursohn, vitamin A, etc., and its pharmacological action is mild, poisonous, tasteful and sweet, and the kidney function and reproductive function deteriorate. It is effective when you take a look, a nightingale, a headache, tinnitus, waist and knee, and when you feel pain in the back.

본 발명에서의 구기자 나무는 학명이 Lycium chinense로서 가지과에 속하는 낙엽성 활엽관목으로서 고춧잎 같이 생긴 어린잎은 식용하며 관상용으로도 심으며 한국 중국, 일본에 분포한다. 열매는 구기자(拘杞子)라 하며 약용으로 사용하는데, 성분은 베타인, 베아크산틴, 카로텐, 티아민, 비타민A, B1, B2, C 등이 함유되어 있으며, 만성간염, 간경변증, 강장제, 해열제로 허리요통에 쓰이고, 뿌리 껍질은 지골피(地骨皮)라 하여 한방에서 소갈, 오한 등의 해열제로 이용된다. Gugija wood in the present invention is the scientific name Lycium Chinense is a deciduous broad-leaved shrub belonging to the genus Chinense. Young leaves like a green leaf are edible and are also planted for ornamental purposes and distributed in Korea, China and Japan. The fruit is called gugija and it is used as a medicinal ingredient. It contains beta-in, beacaxanthin, carotene, thiamine, vitamin A, B1, B2 and C and it is used for chronic hepatitis, cirrhosis, It is used for lower back pain. Root skin is used as antipyretic agent such as peel, chill and so on.

본 발명에서의 생강나무는 학명이 Lindera obtusiloba Blume var. obtusiloba로서 녹나무과에 속하며, 키는 3~4m 내외이고, 잎은 길이가 5~15㎝, 폭은 4~13㎝로 어긋나며 난형 또는 난상 원형, 꽃은 황색으로 가지를 따라 잎보다 먼저 달리고, 열매는 9~10월경에 지름이 0.7~0.8㎝로 둥글게 달리고, 녹색에서 황색 또는 홍색으로 변하며 흑색으로 익는 암수 딴그루의 전국의 야산에서 자라는 낙엽활엽관목이다. 생강나무의 잎은 자라면 심장 모양을 하고 있으며, 줄기를 따보면 식용하는 생강과 같은 향이 나며, 잎과 꽃에서도 그 향이 강하게 난다. In the present invention, the ginger tree has a scientific name Lindera obtusiloba I have Blume . It is obtusiloba and belongs to the camphoraceae . Its height is 3 ~ 4m, the leaves are 5 ~ 15㎝ long, 4 ~ 13㎝ wide and ovate or ovate round, It is a deciduous broad-leaved shrub that grows in the mountains of the country, which is round with the diameter of 0.7 ~ 0.8 ㎝, green to yellow or red, ripe in black, from around September to October. The leaves of the ginger tree are in the shape of a heart when they grow up, and the ginger-like fragrance comes from the stem, and the fragrance is strong even in leaves and flowers.

상술한 바와 같은 산수유 나무의 잎, 구기자 나무의 잎 및 생강나무의 잎 건조 분말을 혼합한 후 열수로 추출된 추출물을 활성 성분으로 하여 항균 활성이 높으면서 그 적용 범위도 내성균주까지로 매우 넓은 항균용 조성물을 만들 수 있음을 발명하게 되어 완성된 것이다.After mixing the above-mentioned leaves of Cornus sylvestris seed oil, leaves of Gujuga tree and leaves of ginger tree, the extract was extracted with hot water and used as an active ingredient. The antimicrobial activity of this extract was high, It is possible to make a composition.

이와 같은 본 발명에서 있어서, 산수유 나무의 잎, 구기자 나무의 잎 및 생강나무의 잎 건조 분말의 혼합물은 채밀이 완료된 벌집 건조 분말을 더 포함하는 것이 항균 활성 및 그 적용 범위에 있어서 더욱 바람직한 효과를 내게 된다.In the present invention, it is preferable that the mixture of the leaves of Sanskrit tree, the leaves of Gugija, and the dry powder of ginger leaf further contains honeycomb dried powder which has been densified to have a more preferable effect in antibacterial activity and its application range do.

채밀이 완료된 벌집 건조 분말은 한봉, 양봉, 자연에서 채집한 것 구별 없이 사용 가능하며, 사용량 역시 특별한 제한이 없으나, 건조한 산수유 잎 분말, 건조한 구기자 잎 분말, 건조한 생강나무 잎 분말 및 채밀이 완료된 벌집 건조 분말의 중량 비율이 동일 비율인 것이 바람직하다.The honeycomb-dried powders that have been densely packed can be collected without any distinction between hanbong, beekeeping, The amount of dried corn oil leaf powder, dried Gugija leaf powder, dried ginger leaf powder and dried honeycomb dried powder is preferably the same ratio.

본 발명에서의 사용되는 벌집에는 곰팡이, 바이러스, 세균 등이 함부로 침투할 수 없는데, 이는 바로 "자연의 페니실린"이라고 불리는 프로폴리스라는 치유 물질 때문이며, 벌들은 이 프로폴리스를 벌집으로 물어와 타액과 효소를 혼합하여 벌집 입구와 바깥벽에 발라 벌집 내부를 언제나 청결한 상태로 유지한다The honeycomb used in the present invention can not infiltrate with mold, virus, bacteria, etc. This is because of the healing substance called propolis called "natural penicillin", and the bees ask the honeycomb of the propolis and the saliva and the enzyme To the honeycomb inlet and outer wall to keep the inside of the honeycomb clean at all times

또한 본 발명에서는 항균 활성을 높이고 그 적용 범위를 확장하기 위하여, 건조한 산수유 잎 분말, 건조한 구기자 잎 분말, 건조한 생강나무 잎 분말 및 채밀이 완료된 벌집 건조 분말의 혼합물에 락토바실러스 플란타룸(Lactobacillus plantarum)을 접종하고 배양한 후 배양물을 열수 추출한 추출물로 활성 성분으로 하여 항균용 조성물을 제조할 수 있다.In order to increase the antimicrobial activity and extend the application range of the present invention, Lactobacillus plantarum is added to a mixture of dried leaves of corn oil, dried Gugija leaf powder, dried ginger leaf powder, And then cultured, and then the culture is subjected to hot-water extraction. As an active ingredient, an antimicrobial composition can be prepared.

상기 락토바실러스 플란타룸(Lactobacillus plantarum)은 김치 발효 후기 생기는 내산성이 강한 막대기 모양의 유산 간균으로서,김치가 발효가 많이 되어 신맛이 날 때 주로 생장하는 균으로 내산성성과 내담즙성이 강한 특성을 가진다. Lactobacillus plantarum is a rod-shaped lactic acid bacterium with a high acid resistance generated in the late stage of kimchi fermentation. It is a bacterium that grows mainly when kimchi is fermented and sour, and has acid fastness and strong bite resistance .

락토바실러스 플란타룸(Lactobacillus plantarum)의 접종을 통한 발효에서 접종량, 발효 조건, 발효 시간 등의 발효 방법은 본 발명이 속하는 기술 분야에 널리 알려진 것이라면 특별한 제한 없이 이용가능하다.Fermentation methods such as inoculation amount, fermentation conditions, and fermentation time in fermentation through inoculation of Lactobacillus plantarum can be used without any particular limitation as long as they are well known in the art to which the present invention belongs.

이하, 본 발명을 하기의 실시예 및 실험예에 의해 상세히 설명한다. 단, 하기 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to the following Examples and Experimental Examples. However, the following examples and experimental examples are illustrative of the present invention, and the content of the present invention is not limited by the following examples and experimental examples.

실시예Example 1. 본 발명에 따른 추출물의 제조 1. Preparation of the extract according to the invention

건조한 산수유 잎, 건조한 구기자 잎, 건조한 생강나무 잎을 각각 1kg씩 분쇄기에 넣고 입자의 크기가 30메시(mesh) 이하가 되도록 분쇄하여 건조 분말을 수득한 후, 상기에서 수득한 건조된 분말의 무게에 3배에 해당하는 증류수를 가하여 100℃에서 3시간 동안 환류 냉각 추출하고 여과 및 감압 농축하여 600g의 추출물을 수득하였다.Dried corn oil leaves, dried Gugija leaves, and dried ginger leaves were each weighed into a grinder in an amount of 1 kg and pulverized to a size of not more than 30 mesh to obtain a dry powder, and then the dried powder was weighed Distilled water corresponding to 3 times was added and the mixture was reflux cooled for 3 hours at 100 ° C, filtered and concentrated under reduced pressure to obtain 600 g of an extract.

실시예Example 2. 본 발명에 따른 추출물의 제조 2. Preparation of the extract according to the present invention

건조한 산수유 잎, 건조한 구기자 잎, 건조한 생강나무 잎, 채밀이 완료된 벌집을 각각 1kg씩 분쇄기에 넣고 입자의 크기가 30메시(mesh) 이하가 되도록 분쇄하여 건조 분말을 수득한 후, 상기에서 수득한 건조된 분말의 무게에 3배에 해당하는 증류수를 가하여 100℃에서 3시간 동안 환류 냉각 추출하고 여과 및 감압 농축하여 600g의 추출물을 수득하였다.Dried corn oil leaves, dried ginger leaf, dry ginger leaf, and honeycomb which has been minced is put into a pulverizer in an amount of 1 kg each, and the pulverized powder is pulverized to have a particle size of 30 mesh or less to obtain a dry powder, Distilled water corresponding to the weight of the powder was added, and the mixture was refluxed at 100 ° C for 3 hours, cooled, and concentrated under reduced pressure to obtain 600 g of an extract.

실시예Example 3. 본 발명에 따른 추출물의 제조 3. Preparation of the extract according to the present invention

건조한 산수유 잎, 건조한 구기자 잎, 건조한 생강나무 잎, 채밀이 완료된 벌집을 각각 1kg씩 분쇄기에 넣고 입자의 크기가 30메시(mesh) 이하가 되도록 분쇄하여 건조 분말을 수득한 후, 락토바실러스 플란타룸(lactobacillus plantarum, KCCM11019P)을 접종하고 배양을 한 후에 이 배양물의 분말의 무게에 3배에 해당하는 증류수를 가하여 100℃에서 3시간 동안 환류 냉각 추출하고 여과 및 감압 농축하여 600g의 추출물을 수득하였다.Each 1 kg of dried corn oil leaves, dried Gugija leaves, dried ginger leaves and dense honeycombs were each pulverized in a pulverizer so as to have a particle size of 30 mesh or less to obtain a dry powder, and then the Lactobacillus planta (lactobacillus plantarum, KCCM11019P) and cultured. Three times of distilled water was added to the weight of the culture, and the mixture was refluxed and cooled at 100 ° C for 3 hours. After filtration and concentration under reduced pressure, 600 g of an extract was obtained.

실험예Experimental Example : 본 발명에 따른 추출물의 항균 활성 측정 : Antimicrobial activity measurement of the extract according to the present invention

본 발명의 추출물의 항균 활성을 알아보기 위하여, 하기와 같은 실험을 수행하였다.In order to examine the antibacterial activity of the extract of the present invention, the following experiment was conducted.

시험균은 Mueller Hinton broth에서 배양하여 액체 배지 희석법(broth microdilution)으로 항균활성을 측정하였다. 대수기 중기까지 배양한 시험균액을 같은 배지에 105/㎖이 되도록 균주를 맞춘 다음, 96 웰 플레이트에 웰 당 0.2㎖ 씩 균주한 다음, 상기 실시예 1 내지 3에서 제조한 시료를 2배수씩 희석하여 처리하였다.The test bacteria were cultured in Mueller Hinton broth and the antimicrobial activity was measured by broth microdilution. The test strains cultured up to the middle of the larval stage were put on a same medium so as to have a concentration of 10 5 / ml, and 0.2 ml per well was added to a 96-well plate. The samples prepared in Examples 1 to 3 were diluted 2-fold Lt; / RTI >

30℃에서 18시간 배양하여 세균의 생육을 650㎚에서 측정하였다. 세균의 생육을 완전히 저해하는 화합물의 최소농도를 MIC로 정의하였으며, 그 결과를 표 1에 나타냈다.And cultured at 30 DEG C for 18 hours to measure the growth of bacteria at 650 nm. The minimum concentration of compounds that completely inhibit the growth of bacteria was defined as MIC, and the results are shown in Table 1.

구분division 균주Strain 특성characteristic 실시예 1Example 1 실시예 2Example 2 실시예 3Example 3 Gram
Positive








Gram
Positive








Staphylococcus aureus CCARM 0203 Staphylococcus aureus CCARM 0203 감수성sensibility 0.50.5 0.50.5 0.50.5
Staphylococcus aureus CCARM 0204 Staphylococcus aureus CCARM 0204 감수성sensibility 0.50.5 0.50.5 0.50.5 Staphylococcus aureus CCARM 0205 Staphylococcus aureus CCARM 0205 감수성sensibility 0.50.5 0.50.5 0.50.5 Staphylococcus aureus CCARM 3505 Staphylococcus aureus CCARM 3505 QRSAQRSA 1.71.7 1.31.3 1.01.0 Staphylococcus aureus CCARM 3002 Staphylococcus aureus CCARM 3002 MRSAMRSA 1.51.5 1.31.3 1.01.0 Staphylococcus aureus CCARM 3196 Staphylococcus aureus CCARM 3196 MRSAMRSA 1.71.7 1.31.3 1.01.0 Staphylococcus aureus CCARM 3579 Staphylococcus aureus CCARM 3579 MRSAMRSA 1.51.5 1.31.3 1.01.0 Enterococcus feacium CCARM 5212 Enterococcus feacium CCARM 5212 감수성sensibility 0.50.5 0.50.5 0.50.5 Enterococcus feacium CCARM 5024 Enterococcus feacium CCARM 5024 VRE
(VanA)
VRE
(VanA)
1.61.6 1.31.3 1.01.0
Enterococcus feacium CCARM 5025 Enterococcus feacium CCARM 5025 VRE
(VanB)
VRE
(VanB)
1.71.7 1.31.3 1.01.0
Gram
Negarive






Gram
Negarive






Escherichia coli CCARM 0230 Escherichia coli CCARM 0230 감수성sensibility 0.50.5 0.50.5 0.50.5
Escherichia coli CCARM 0237 Escherichia coli CCARM 0237 감수성sensibility 0.50.5 0.50.5 0.50.5 Salmonella typhimurium CCARM 0240 Salmonella typhimurium CCARM 0240 감수성sensibility 0.50.5 0.50.5 0.50.5 Pseudimonas aeruginosa CCARM 0225 Pseudomonas aeruginosa CCARM 0225 감수성sensibility 0.50.5 0.50.5 0.50.5 Klebsiella oxytoca CCARM 0249 Klebsiella oxytoca CCARM 0249 감수성sensibility 0.50.5 0.50.5 0.50.5 Escherichia coli CCARM 1136 Escherichia coli CCARM 1136 MDRMDR 1.71.7 1.31.3 1.01.0 Escherichia coli CCARM 1137 Escherichia coli CCARM 1137 MDRMDR 1.71.7 1.31.3 1.01.0 Pseudimonas aeruginosa CCARM 2009 Pseudomonas aeruginosa CCARM 2009 MDRMDR 1.71.7 1.31.3 1.01.0 Pseudimonas aeruginosa CCARM 2203 Pseudomonas aeruginosa CCARM 2203 MDRMDR 1.71.7 1.31.3 1.01.0 Salmonella typhimurium CCARM 8002 Salmonella typhimurium CCARM 8002 MDRMDR 1.71.7 1.31.3 1.01.0

표 1에 나타난 바와 같이, 본 발명에 따른 추출물은 그람 음성균, 그람 양성균의 항생제 감수성 균주뿐만 아니라 반코마이신 내성균주(VRE), 메치실린 내성균주(MRSA), 퀴놀론 내성균주(QRSA), 다제내성균주(MDR)에도 매우 우수한 항균활성을 보임을 알 수 있습니다.As shown in Table 1, the extract according to the present invention can be used as an antibiotic-sensitive strain of Gram-positive bacteria or Gram-positive bacteria, as well as vancomycin resistant strains (VRE), methicillin resistant strains (MRSA), quinolone resistant strains (QRSA) MDR) has also shown excellent antibacterial activity.

하기에 본 발명의 조성물을 위한 제제예를 예시한다.Examples of formulations for the composition of the present invention are illustrated below.

제제예 1 : 산제의 제조Formulation Example 1: Preparation of powder

추출물 0.1 g0.1 g of extract

유당 1.5 gLactose 1.5 g

탈크 0.5 gTalc 0.5 g

상기의 성분들을 혼합하고 기밀포에 충진하여 산제를 제조하였다.The above ingredients were mixed and filled in an airtight container to prepare powders.

제제예 2 : 정제의 제조Formulation Example 2: Preparation of tablets

추출물 0.1 g0.1 g of extract

락토오스 7.9gLactose 7.9 g

결정성 셀룰로오스 1.5 gCrystalline cellulose 1.5 g

마그네슘 스테아레이트 0.5 g0.5 g of magnesium stearate

상기의 성분들을 혼합한 후 직타법(direct tableting method)으로 정제를 제조하였다.After mixing the above ingredients, tablets were prepared by direct tableting method.

제제예 3 : 캡슐제의 제조Formulation Example 3: Preparation of capsules

추출물 0.1 g0.1 g of extract

옥수수전분 5 gCorn starch 5 g

카르복시 셀룰로오스 4.9 g4.9 g of carboxycellulose

상기의 성분들을 혼합하여 분말을 제조한 후, 상기 분말을 통상의 캡슐제의 제조방법에 따라 경질 캡슐에 충전하여 캡슐제를 제조하였다.After mixing the above components to prepare a powder, the powder was filled in a hard capsule according to a conventional preparation method of a capsule to prepare a capsule.

제제예 4 : 주사제의 제조Formulation Example 4: Preparation of injection

추출물 0.1 g0.1 g of extract

주사용 멸균 증류수 적량Sterile sterilized water for injection

pH 조절제 적량pH adjuster

통상의 주사제의 제조방법에 따라 1 앰플 당(2㎖) 상기의 성분 함량으로 제조하였다.(2 ml) per 1 ampoule in accordance with the usual injection preparation method.

제제예 5 : 액제의 제조Formulation Example 5: Preparation of a liquid preparation

추출물 0.1 g0.1 g of extract

이성화당 10 g10 g per isomer

만니톨 5 g5 g mannitol

정제수 적량Purified water quantity

통상의 액제의 제조방법에 따라 정제수에 각각의 성분을 가하여 용해시키고, 레몬향을 적량 가한 다음 상기의 성분을 혼합하였다. 그 다음 정제수를 가하여 전체 100 ㎖로 조절한 후 갈색병에 충진하여 멸균시켜 액제를 제조하였다.Each component was dissolved in purified water in accordance with a conventional method for producing a liquid agent, and the lemon flavor was added in an appropriate amount, followed by mixing the above components. Then, purified water was added to adjust the total volume to 100 ml, and the solution was filled in a brown bottle and sterilized to prepare a liquid preparation.

Claims (5)

건조한 산수유 잎 분말, 건조한 구기자 잎 분말, 건조한 생강나무 잎 분말 및 채밀이 완료된 벌집 건조 분말의 혼합물을 열수 추출하여 제조되는 것을 특징으로 하는 광범위한 항균 활성을 가지는 항균용 조성물.
Characterized in that the composition is prepared by hot extraction of a mixture of dried corn oil leaves, dried Goujita leaf powder, dried ginger leaf powder and honeycomb dried powder that has been compacted.
제 1항에 있어서, 상기 혼합물에 락토바실러스 플란타룸(Lactobacillus plantarum)을 접종하고 배양한 후 배양물을 열수 추출하여 제조되는 것을 특징으로 하는 광범위한 항균 활성을 가지는 항균용 조성물.
The antimicrobial composition according to claim 1, wherein the mixture is inoculated with Lactobacillus plantarum and cultured, and then the culture is subjected to hot water extraction.
제 1항에 있어서,
상기 건조한 산수유 잎 분말, 건조한 구기자 잎 분말, 건조한 생강나무 잎 분말 및 채밀이 완료된 벌집 건조 분말의 중량 비율이 동일 비율인 것을 특징으로 하는 광범위한 항균 활성을 가지는 항균용 조성물.
The method according to claim 1,
Wherein the weight ratio of the dry powder of corn oil to the dried gugija leaf powder, the dry ginger leaf powder, and the honeycomb dried powder having been densified is the same ratio.
제 1항에 있어서,
상기 항균 활성이 반코마이신 내성균주(VRE), 메치실린 내성균주(MRSA), 퀴놀론 내성균주(QRSA) 및 다제내성균주(MDR)에 대하여 활성을 보이는 것을 특징으로 하는 광범위한 항균 활성을 가지는 항균용 조성물.
The method according to claim 1,
Wherein the antimicrobial activity is active against vancomycin resistant strains (VRE), methicillin resistant strains (MRSA), quinolone resistant strains (QRSA) and multidrug resistant strains (MDR).
삭제delete
KR1020160119261A 2016-09-19 2016-09-19 Antibiotic composition having a wide scope of antibacterial activity untill drug resistance bacteria KR101739122B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160119261A KR101739122B1 (en) 2016-09-19 2016-09-19 Antibiotic composition having a wide scope of antibacterial activity untill drug resistance bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160119261A KR101739122B1 (en) 2016-09-19 2016-09-19 Antibiotic composition having a wide scope of antibacterial activity untill drug resistance bacteria

Publications (1)

Publication Number Publication Date
KR101739122B1 true KR101739122B1 (en) 2017-05-29

Family

ID=59053575

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160119261A KR101739122B1 (en) 2016-09-19 2016-09-19 Antibiotic composition having a wide scope of antibacterial activity untill drug resistance bacteria

Country Status (1)

Country Link
KR (1) KR101739122B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101656791B1 (en) * 2016-05-19 2016-09-12 이우철 Composition of feed additives having anti-virus activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101656791B1 (en) * 2016-05-19 2016-09-12 이우철 Composition of feed additives having anti-virus activity

Similar Documents

Publication Publication Date Title
Al-Sieni The antibacterial activity of traditionally used Salvadora persica L.(miswak) and Commiphora gileadensis (palsam) in Saudi Arabia
KR102234568B1 (en) Cosmetic composition for improving skin inflammation comprising fermentated extract of inula britannica flowers and method for prparing thereof
KR101806800B1 (en) Complex natural preservative comprising scutellaria baicalensis extract and method manufacture the same
KR101715622B1 (en) Antimicrobial composition comprising the extraction of suaeda spp as an effective component
KR101941753B1 (en) a functional antiseptic composite for wet wipes
KR101590492B1 (en) Disinfectant composition comprising fermented natural product as effective component and production method thereof
KR101298184B1 (en) Antibacterial compositions against fish disease bacteria
KR20090091492A (en) An antibacterial composition and a method for preparing the same
Ugbabe et al. Preliminary phytochemical, antimicrobial and acute toxicity studies of the stem, bark and the leaves of a cultivated Syzygium cumini Linn.(Family: Myrtaceae) in Nigeria
KR102133268B1 (en) Prevent, improve and treat acne through the composition of natural extracts
KR101270972B1 (en) Antifungal composition containing plant extracts
KR101739122B1 (en) Antibiotic composition having a wide scope of antibacterial activity untill drug resistance bacteria
KR101506858B1 (en) Herbal Extract for Having an Antibacterial and Antibiofilm Effect on Oral Pathogen
KR102594674B1 (en) Oral composition comprising herbal complex
KR20180006551A (en) Antimircrobial Composition Including a Extract Derived from Torreya nucifera
KR20220094308A (en) Pharmaceutical composition for preventing or treating infectious symptoms by pathogenic microorganism comprising Cichorium intybus extract as an active ingredient
KR101928211B1 (en) Composition having inhibitory effect on microorganism and virus including enterovirus 71 causing hand-foot-mouth symptom
KR20090046387A (en) Functional cosmetic composition comprising scutellaria,houttuynia,artemisia,citurs junos extract having antimicrobial activity
KR101884627B1 (en) Composition comprising natural herbs essential having antibiotic activity and process thereof
KR20140047563A (en) Composition for inhibiting quorum sensing or anti-bacterial composition comprising nymphaea tetragona georgi extract
KR20150037774A (en) Preparation of clove having enhanced antioxidative effect
Umadevi et al. ANTIMICROBIAL ACTIVITY OF THREE INDIAN MEDICINAL PLANTS- AN IN VITRO STUDY
KR20130109765A (en) Herbal extract for preventing and treating disease of oral cavity
BANDYOPADHYAY et al. Evaluation of methanolic extract of Allium sativum and Saussurea costus in yaks with infectious keratoconjunctivitis
KR101426238B1 (en) Herbal Extract For Preventing and Treating Disease of Oral Cavity

Legal Events

Date Code Title Description
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant